Search

everythinglearnresearchcommunity

for

Search:↓

Nanotechnology is improving drug delivery and targeting, with promising applications in cancer treatment, gene therapy, and cosmetics, but challenges remain in ensuring precise delivery and safety.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Eph receptors and ephrins may be promising targets for treating diseases, but more understanding is needed for effective and safe therapies.

The WNT signaling pathway is important in many diseases and targeting it could offer new treatments.

Low fluence photoepilation temporarily removes hair by targeting the hair follicle's pigmented area without severe damage.

Eph/ephrin signaling is important for skin cell behavior and could be targeted to treat skin diseases.

Ca_v1.2 affects hair growth and could be a target for hair loss treatments.

New patents show progress in developing drugs targeting the Wnt pathway for diseases like cancer and hair loss.

CRISPR/Cas systems show promise for cancer treatment by targeting miRNAs, but delivery and specificity challenges remain.

Nanoparticles improve cancer treatment by reducing side effects and targeting cancer cells better.

Hair follicles could be used for targeted drug delivery, with liposomal systems showing promise for this method.

Platycladi Cacumen may help treat hair loss by targeting specific proteins and pathways.

Astragaloside A may help fight lung cancer by targeting specific proteins.

Alzheimer's may be treated by targeting gut bacteria and inflammation.

Some existing drugs and natural products might work against COVID-19 by targeting the virus's main protease.

Potassium channel openers could help treat cardiovascular diseases and asthma but require better targeting to specific tissues for effective use.

PTHrP is important for bone formation and may be targeted for osteoporosis treatment and longevity therapies.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

MicroRNAs are important for skin health and could be targets for new skin disorder treatments.

Lysophosphatidic acid is important for skin health and disease, and could be a target for new skin disorder treatments.

CEP135 may predict cancer outcomes, and targeting PLK1 could help treat certain sarcomas.

KATP channels are important for energy balance and are targeted by drugs for diabetes, hypoglycemia, hypertension, and hair loss.

New treatments for vitiligo may focus on protecting melanocyte stem cells from stress and targeting specific pathways involved in the condition.

Avicennia marina shows potential to treat Hepatitis C by targeting key proteins.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

EMT plays a key role in skin fibrosis and offers new therapy targets.

Nanotechnology could improve treatment for scars and atopic dermatitis by targeting skin issues more effectively.

Stiffness gradients in alginate gels can guide cancer cell invasion and study cellular behaviors.

Type-2 immunity may influence skin diseases and could be targeted for treatment.

Two microRNAs affect hair follicle development in sheep by targeting specific genes.